Diseases [C] » Respiratory Tract Diseases [C08] » Nose Diseases
Diseases [C] » Otorhinolaryngologic Diseases [C09] » Nose Diseases
Description
Disorders of the nose, general or unspecified. MeSH
Hierarchy View
Subtype Terms (11)
Choanal Atresia
1 approved drug
Epistaxis
22 drugs (18 approved, 4 experimental)
Nasal Obstruction
50 drugs (41 approved, 9 experimental)
Nasal Polyps
41 drugs (30 approved, 11 experimental)
Nasal Septal Perforation
11 drugs (8 approved, 3 experimental)
Nose Deformities, Acquired
3 approved drugs
Nose Neoplasms
6 drugs (5 approved, 1 experimental)
Paranasal Sinus Diseases
9 drugs (7 approved, 2 experimental)
Rhinitis
62 drugs (42 approved, 20 experimental)
Rhinoscleroma
4 approved drugs
Approved Indicated Drugs (1)
Phase 4 Indicated Drugs (1)
Other Experimental Indicated Drugs (1)
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (1)
Organization Involved with Phase 2 Indications (2)
Organization Involved with Other Experimental Indications (3)
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
